Serious Adverse Drug Reaction Research (R21)

The summary for the Serious Adverse Drug Reaction Research (R21) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Serious Adverse Drug Reaction Research (R21): This Funding Opportunity Announcement is to support research grants that will advance the state of knowledge of serious adverse drug reactions. Applications across the spectrum of research are encouraged.
Federal Grant Title: Serious Adverse Drug Reaction Research (R21)
Federal Agency Name: National Institutes of Health
Grant Categories: Education Health
Type of Opportunity: Discretionary
Funding Opportunity Number: PAR-16-274
Type of Funding: Grant
CFDA Numbers: 322650, 322653, 322651, 322656, 322655, 322657, 322654, 322652, 322659, 322658, 322660
CFDA Descriptions: Human Genome Research; Minority Health and Health Disparities Research; Cancer Cause and Prevention Research; Cancer Detection and Diagnosis Research; Cancer Treatment Research; Cancer Control; Arthritis, Musculoskeletal and Skin Diseases Research; Extramural Research Programs in the Neurosciences and Neurological Disorders; Allergy and Infectious Diseases Research; Microbiology and Infectious Diseases Research
Current Application Deadline: Sep 7, 2019
Original Application Deadline: Sep 7, 2019
Posted Date: May 19, 2016
Creation Date: May 19, 2016
Archive Date: Oct 8, 2019
Total Program Funding:
Maximum Federal Grant Award: $200,000
Minimum Federal Grant Award: none
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
State governments
Private institutions of higher education
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Public and State controlled institutions of higher education
Independent school districts
Native American tribal governments (Federally recognized)
For profit organizations other than small businesses
Native American tribal organizations (other than Federally recognized tribal governments)
Public housing authorities/Indian housing authorities
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
City or township governments
Small businesses
County governments
Special district governments
Additional Information on Eligibility
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Link to Full Grant Announcement
http://grants.nih.gov/grants/guide/pa-files/PAR-16-274.html
Grant Announcement Contact
NIH OER Webmaster FBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

National Institutes of Health 301-496-3405
More Grants from the National Institutes of Health
Feasibility and Planning Studies for Development of Specialized Programs of Research Excel...
Minority-Patient Derived Xenograft (PDX) Development and Trial Center (PDTC) Network (U54)
Fundamental Science Research on Mind and Body Approaches (R01 - Clinical Trial Optional)
Fundamental Science Research on Mind and Body Approaches (R21 - Clinical Trial Optional)
HIV Vaccine Research and Design (HIVRAD) Program (P01 Clinical Trial Not Allowed)

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2017 FederalGrants.com